Key result
Restricted mean time lost improves clinical interpretation of CV trial outcomes with competing risks.
Key points are not available for this paper at this time.
This study explores using the restricted mean time lost to quantify treatment effects from cardiovascular therapy.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2018) studied this question. Restricted mean time lost provides a methodological approach to quantify and clinically interpret treatment effects in cardiovascular trials with endpoints subject to competing risks.
Synapse has enriched 5 related papers. Consider them for comparative context: